The latest #MedStory episode explores groundbreaking #StanDOM research that examines the safety of #GLP1 receptor agonists, like Ozempic & Wegovy, in #CriticalCare settings. Findings suggest these popular drugs do not negatively affect patient outcomes in the #ICU. https://bit.ly/4t1xyzH

In the latest #MedStory, #StanDOM clinicians Albert Park & Neera Ahuja discuss a new study examining whether #GLP1 receptor agonists impact outcomes for critically ill patients. Their findings suggest these medications do not worsen critical care outcomes. stanford.io/458jNEX

You’ve Likely Had This Virus. Here’s How It Can Trigger MS Most people recover from Epstein-Barr virus (EBV) without issue. But new research shows how, in some, it may trigger multiple sclerosis (MS) through a case of immune system “mistaken identity.” Learn how this common virus can set off a serious autoimmun...

How can a common virus spark a lifelong disease? Rebecca Handler, MSc, breaks down a Stanford study that reveals how #EpsteinBarrVirus, the culprit behind mono, can trigger #MultipleSclerosis in those who carry certain genetic risk factors. #MedStory https://bit.ly/4nHaToW

ICYMI: In the latest #MedStory episode, host Rebecca Handler unpacks a Stanford-led study showing how the #EpsteinBarrVirus (EBV) may trigger #MultipleSclerosis in some people — & what this means for future prevention. https://bit.ly/4nHaToW

New #MedStory episode now live! Host Rebecca Handler explores a Stanford-led study showing how the Epstein-Barr virus (EBV)—best known for causing mono—can trigger MS in genetically susceptible people. https://stanford.io/4nuO8o8

#StanDOM PhD candidate Jason Nideffer discusses immune memory & #malaria response. His team's research on T cells may explain why some children get repeated malaria but avoid severe illness—insights that could shape new vaccines. #MedStory stanford.io/46liLqy%22

How do some children avoid serious illness from repeated malaria infections? #StanDOM-led research points to an "immune braking system" that has implications for broader vaccine strategies. More in #MedStory: stanford.io/46liLqy

How the Immune System Remembers Malaria How does the Immune System Remembers Malaria? Researchers from Stanford have recently discovered a correlation of children in Uganda who have been infected by Malaria multiple times; and discovered that specialized CD4 T cells have played a part in building the body's immune response. The type 1 regulatory T (Tr1) cells helps the body remember it's defense against Malaria, which plays an important part in fighting off the disease. This immune response helps create immune memory, of which is the first observed action within humans. With this research, vaccine development might help create better outcomes to those afflicted with Malaria, which affect 260 million people and causes nearly 600,000 deaths world-wide. Learn more in this new episode of MedStory, hosted by Katie M. Kanagawa, PhD.

A specific group of T cells may explain why certain Ugandan children face severe illness when infected with #malaria — & others don't. Our latest #MedStory dives deeper into research led by DOM's Jason Fairbank Nideffer, Prasanna Jagannathan & Maria-Grazia Roncarolo: bit.ly/4fc6CXs

In this new episode of #MedStory with Rebecca Handler, learn about Tracey McLaughlin & Michael Snyder's new #AI model that analyzes continuous glucose monitoring data to pinpoint & predict each patient's unique subtype of #Type2Diabetes or #prediabetes. stanford.io/4iOXRDx

"We were surprised how good this model worked… In #BreastCancer, we can predict up to 15,000 genes with high accuracy" says #StanDOM's Olivier Gevaert, discussing his work using #AI to improve #cancer diagnostics. #MedStory bit.ly/3EAn2dM

#StanDOM's Rebecca Handler & Olivier Gevaert discuss SEQUOIA, an #AI tool that predicts gene activity from #tumor images, reducing costs & making #PrecisionMedicine more accessible. #MedStory #CancerDiagnostics stanford.io/3EBUMYs

Curious about CAR-T Cell Therapy? Science communicator Rebecca Handler simplifies this groundbreaking cancer treatment in just two minutes. Watch the latest #MedStory Mini to learn how research at Stanford is improving cancer care. bit.ly/4iy5K0m

MedStory Science Podcast · 7 Episodes

Just subscribed to #MedStory by @brandonbrownmd from @IURadiology and stoked to listen. itunes.apple.com/us/podcast/medstories/id...